Robert F. Kennedy Jr., the Secretary of Health and Human Services, has recently made significant changes to the federal Vaccination Practice Advisory Committee, dismissing all existing members and appointing eight new individuals in their place.
This swift overhaul aligns with the administration’s trend of prioritizing personnel who align with its agenda. Kennedy, however, defended these changes, stating they were essential, particularly noting that a former committee member had a conflict of interest with a pharmaceutical company.
It should be acknowledged that the new members, despite not being part of the mainstream vaccination community, are quite accomplished in their fields. The critical question remains whether their expertise aligns with the advisory board’s responsibilities and how their diverse perspectives will serve the nation’s vaccination policies.
I can’t speak for all the new members, but I do have some familiarity with two of them—Martin Kulldorff and Retsef Levi. They both graduated from Cornell University’s Doctoral Program in Operations Research, which is where I got my degree as well.
Operations research is a field that employs mathematical models to aid decision-making, widely applied in various sectors including government, transportation, healthcare, and finance.
Kulldorff has a background in probability theory, which led him to focus on health policy and biostatistics. He has been part of Harvard Medical School’s faculty for close to twenty years. He gained notable recognition during the pandemic for his contrary views to prevailing public health advice, advocating for the protection of the most vulnerable while supporting natural immunity for younger individuals, as outlined in his co-authored position paper, The Great Barrington Declaration.
Levi teaches at MIT’s Sloan Management School and specializes in mathematical modeling aimed at risk reduction. His research covers a wide array of healthcare issues, reflecting a deep commitment to the field, as showcased in his extensive list of publications. He’s also associated with the Mass General Research Institute.
It raises a question—why are some expressing concern over these two individuals, along with the six other new advisory committee members, who will play a role in shaping U.S. vaccination policies? The apprehension stems from their non-mainstream views, which diverge from those historically held by the previous committee members.
This shift means that the recommendations coming from this new committee could significantly differ from what was previously outlined.
One area where this could be evident is in the vaccination schedules for children and adolescents, a key responsibility of the committee. But it’s essential to keep in mind that any potential changes to this schedule aren’t likely to be abrupt, given the extensive research and data supporting existing vaccines.
While the newcomers may hold views that aren’t widely accepted, their expertise suggests they will carefully consider the data and avoid hasty decisions that could negatively impact public health or health insurance.
If Kennedy had opted to introduce some of these new figures gradually instead of dismissing the entire committee, it’s likely there would have been less pushback from various professional associations, which are now calling for the reinstatement of ousted members. Instead, he took a more drastic route.
A recent article in JAMA, co-authored by the sacked members, details the historical benefits of vaccines and critiques the manner in which they were dismissed, as well as the potential implications of the newly formed committee.
With a committee of this size, some are questioning whether Kennedy might reconsider and restore some of the dismissed members to foster a healthier debate environment. Ideally, a committee with diverse viewpoints is less likely to produce flawed policies. The first meeting, occurring today, will be a telling test of this new group.
If Kennedy is confident in his beliefs, he should embrace some dissent within the committee. A balanced environment would ensure that all perspectives are represented and that the necessary data used does not skew towards any single ideology. This approach could alleviate politicization surrounding new recommendations and guide vaccination policies more effectively for public health.
Dr. Sheldon H. Jacobson is a professor at Graininger University and Carl Illinois School of Medicine at the University of Illinois at Urbana-Champaign.
